Moreover, obesity-related neuroinflammation has been shown to impair serotonin transporter (SERT) expression in the hippocampus, potentially elucidating the diminished responsiveness to SSRIs observed in obese individuals with comorbid depression (54). The gene discussed is SLC6A4; the disease is depressive symptom measurement.